Figure 4
From: ATG101-related signature predicts prognosis and therapeutic option in hepatocellular carcinoma
Comprehensive analyses of genomic alterations and biological process of ATS. (A) DEGs between ATS-low and ATS-high groups. (B) GSEA plot showing the enriched gene sets in ATS subgroups. (C) Mutation profiles of the top 20 most commonly mutated genes in ATS subgroups. (D) Prognosis effect of the differently mutated genes. (E) A lollipop plot demonstrating the differences in TP53 mutation locations between two cohorts. (F) The heatmap illustrating the co-occurrence and mutually exclusive mutations of the top frequently mutated genes.
